OBJECTIVE: To determine whether peroxisome proliferator-activated receptor (PPAR) gamma ligands improve survival of patients with septic shock we treated a mouse model of sepsis [apolipoprotein (Apo) E) knockout mice] with pioglitazone, a PPAR-gamma ligand. ApoE knockout mice have a high mortality rate due to sepsis because the endotoxin is not cleared. DESIGN AND SETTING: Prospective study in a university laboratory. SUBJECTS: We assorted 87 male ApoE knockout mice and 60 wild-type C57/B6 mice randomly into three groups (sepsis, pretreatment, posttreatment). INTERVENTIONS: Cecal ligation and puncture (CLP) was carried out in the sepsis and treatment groups. Mice were injected with pioglitazone (5 mg/kg per day) on the day before CLP or 6 h after surgery. MEASUREMENTS AND RESULTS: Both pre- and post-CLP treatment with pioglitazone improved survival of ApoE knockout and wild-type mice. Serum levels of cytokines and chemokines and myeloperoxidase activity in lung and liver were suppressed in the pioglitazone-treated group. Pioglitazone also suppressed monocyte adhesion to vascular endothelium under flow conditions. CONCLUSIONS: Pioglitazone improved survival of ApoE knockout mice after onset of septic shock through suppression of inflammatory responses.
OBJECTIVE: To determine whether peroxisome proliferator-activated receptor (PPAR) gamma ligands improve survival of patients with septic shock we treated a mouse model of sepsis [apolipoprotein (Apo) E) knockout mice] with pioglitazone, a PPAR-gamma ligand. ApoE knockout mice have a high mortality rate due to sepsis because the endotoxin is not cleared. DESIGN AND SETTING: Prospective study in a university laboratory. SUBJECTS: We assorted 87 male ApoE knockout mice and 60 wild-type C57/B6 mice randomly into three groups (sepsis, pretreatment, posttreatment). INTERVENTIONS: Cecal ligation and puncture (CLP) was carried out in the sepsis and treatment groups. Mice were injected with pioglitazone (5 mg/kg per day) on the day before CLP or 6 h after surgery. MEASUREMENTS AND RESULTS: Both pre- and post-CLP treatment with pioglitazone improved survival of ApoE knockout and wild-type mice. Serum levels of cytokines and chemokines and myeloperoxidase activity in lung and liver were suppressed in the pioglitazone-treated group. Pioglitazone also suppressed monocyte adhesion to vascular endothelium under flow conditions. CONCLUSIONS:Pioglitazone improved survival of ApoE knockout mice after onset of septic shock through suppression of inflammatory responses.
Authors: Marc W Merx; Elisa A Liehn; Jürgen Graf; Annette van de Sandt; Maren Schaltenbrand; Jürgen Schrader; Peter Hanrath; Christian Weber Journal: Circulation Date: 2005-07-05 Impact factor: 29.690
Authors: Yan Li; Xuemei Li; Michael Haley; Yvonne Fitz; Eric Gerstenberger; Steven M Banks; Peter Q Eichacker; Xizhong Cui Journal: Intensive Care Med Date: 2006-06-15 Impact factor: 17.440
Authors: M Van Oosten; P C Rensen; E S Van Amersfoort; M Van Eck; A M Van Dam; J J Breve; T Vogel; A Panet; T J Van Berkel; J Kuiper Journal: J Biol Chem Date: 2001-01-02 Impact factor: 5.157
Authors: Huan Yang; Mahendar Ochani; Jianhua Li; Xiaoling Qiang; Mahira Tanovic; Helena E Harris; Srinivas M Susarla; Luis Ulloa; Hong Wang; Robert DiRaimo; Christopher J Czura; Haichao Wang; Jesse Roth; H Shaw Warren; Mitchell P Fink; Matthew J Fenton; Ulf Andersson; Kevin J Tracey Journal: Proc Natl Acad Sci U S A Date: 2003-12-26 Impact factor: 11.205
Authors: Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg Journal: Curr Heart Fail Rep Date: 2015-04
Authors: Jerry R Aldridge; Carson E Moseley; David A Boltz; Nicholas J Negovetich; Cory Reynolds; John Franks; Scott A Brown; Peter C Doherty; Robert G Webster; Paul G Thomas Journal: Proc Natl Acad Sci U S A Date: 2009-03-11 Impact factor: 11.205
Authors: Jennifer M Kaplan; Alvin Denenberg; Marie Monaco; Marchele Nowell; Hector Wong; Basilia Zingarelli Journal: Intensive Care Med Date: 2009-09-17 Impact factor: 17.440
Authors: Aravind T Reddy; Sowmya P Lakshmi; Jennifer M Kleinhenz; Roy L Sutliff; C Michael Hart; Raju C Reddy Journal: J Immunol Date: 2012-10-26 Impact factor: 5.422